A-kinase anchoring proteins: Trafficking in G-protein-coupled receptors and the proteins that regulate receptor biology

Current Opinion in Drug Discovery and Development

Volumn 10, Issue 5, 2007, Pages 573-579

  Malbon, C C ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

2 adrenergic receptors; AKAP12; AKAP5; AKAP79 150; AKAPs; Gravin; Trafficking

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC AMP DEPENDENT PROTEIN KINASE ANCHORING PROTEIN; G PROTEIN COUPLED RECEPTOR; ION CHANNEL; PHOSPHOPROTEIN PHOSPHATASE; PROTEIN KINASE; RECEPTOR PROTEIN; SCAFFOLD PROTEIN;

CATALYSIS; CELL COMPARTMENTALIZATION; CELL MIGRATION; ENZYME ACTIVITY; ENZYME BINDING; MYRISTYLATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN TARGETING; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION;

A KINASE ANCHOR PROTEINS; AMINO ACID SEQUENCE; ANIMALS; DRUG DESIGN; HUMANS; MACROMOLECULAR SUBSTANCES; MOLECULAR SEQUENCE DATA; PROTEIN TRANSPORT; RECEPTORS, G-PROTEIN-COUPLED; SIGNAL TRANSDUCTION;

EID: 34548379109     PISSN: 13676733     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (92)

1. Schlessinger J: Cell signaling by receptor tyrosine kinases. Cell (2000) 103(2):211-225.
2. Hinnebusch AG: eIF3: A versatile scaffold for translation initiation complexes. Trends Biochem Sci (2006) 31(10):553-562.
3. Mitulovic G, Mechtler K: HPLC techniques for proteomics analysis - a short overview of latest developments. Brief Funct Genomic Proteomic (2006) 5(4):249-260.
4. Hollywood K, Brison DR, Goodacre R: Metabolomics: Current technologies and future trends. Proteomics (2006) 6(17):4716-4723.
5. White MF, Kahn CR: The insulin signaling system. J Biol Chem (1994) 269(1):1-4.
6. Malbon CC, Wang HY: Dishevelled: A mobile scaffold catalyzing development. Curr Top Dev Biol (2006) 72:153-166.
7. Pawson T: Specificity in signal transduction: From phosphotyrosine-SH2 domain interactions to complex cellular systems. Cell (2004) 116(2):191-203.
8. Pawson T, Nash P: Assembly of cell regulatory systems through protein interaction domains. Science (2003) 300(5618):445-452.
9. Papin JA, Hunter T, Palsson BO, Subramaniam S: Reconstruction of cellular signalling networks and analysis of their properties. Nat Rev Mol Cell Biol (2005) 6(2):99-111.
10. Boutros M, Mlodzik M: Dishevelled: At the crossroads of divergent intracellular signaling pathways. Mech Dev (1999) 83(1-2):27-37.
11. Morris AJ, Malbon CC: Physiological regulation of G protein-linked signaling. Physiol Rev (1999) 79(4):1373-1430.
12. Schlessinger J, Lemmon MA: Nuclear signaling by receptor tyrosine kinases: The first robin of spring. Cell (2006) 127(1):45-48.
13. Saltiel AR, Kahn CR: Insulin signalling and the regulation of glucose and lipid metabolism. Nature (2001) 414(6865):799-806.
14. Laviola L, Natalicchio A, Giorgino F: The IGF-I signaling pathway. Curr Pharm Des (2007) 13(7):663-669.
15. Premont RT, Gainetdinov RR: Physiological roles of G protein-coupled receptor kinases and arrestins. Annu Rev Physiol (2007) 69:511-534. • Provides an outstanding and timely review of the roles of GPCR kinases and the critically important arrestin adaptor molecules in signaling.
16. Luttrell LM: Transmembrane signaling by G protein-coupled receptors. Methods Mol Biol (2006) 332:3-49. • Provides a thoughtful and timely review of GPCR signaling, including physiological considerations.
17. Pierce KL, Premont RT, Lefkowitz RJ: Seven-transmembrane receptors. Nat Rev Mol Cell Biol (2002) 3(9):639-650.
18. Palczewski K, Kumasaka T, Hori T, Behnke CA, Motoshima H, Fox BA, Le Trong I, Teller DC, Okada T, Stenkamp RE, Yamamoto M et al: Crystal structure of rhodopsin: A G protein-coupled receptor. Science (2000) 289(5480):739-745.
19. Malbon CC: Frizzleds: New members of the superfamily of G-protein-coupled receptors. Front Biosci (2004) 9:1048-1058.
20. Malbon CC: G proteins in development. Nat Rev Mol Cell Biol (2005) 6(9):689-701.
21. Singer SJ, Nicolson GL: The fluid mosaic model of the structure of cell membranes. Science (1972) 175(23):720-731.
22. Moore CA, Milano SK, Benovic JL: Regulation of receptor trafficking by GRKs and arrestins. Annu Rev Physiol (2007) 69:451-482.
23. Lefkowitz RJ, Shenoy SK: Transduction of receptor signals by β-arrestins. Science (2005) 308(5721):512-517. •• Provides an outstanding review of the expanding role of arrestins in GPCR signaling and beyond.
24. Steinberg SF, Brunton LL: Compartmentation of G protein-coupled signaling pathways in cardiac myocytes. Annu Rev Pharmacol Toxicol (2001) 41:751-773.
25. Krebs EG: Protein kinases. Curr Top Cell Regul (1972) 5:99-133.
26. Chow CW, Davis RJ: Proteins kinases: Chromatin-associated enzymes? Cell (2006) 127(5):887-890. •• Provides an important review that links protein kinases and transcription in new ways.
27. Pokholok DK, Zeitlinger J, Hannett NM, Reynolds DB, Young RA: Activated signal transduction kinases frequently occupy target genes. Science (2006) 313(5786):533-536.
28. Das R, Esposito V, Abu-Abed M, Anand GS, Taylor SS, Melacini G: cAMP activation of PKA defines an ancient signaling mechanism. Proc Natl Acad Sci USA (2007) 104(1):93-98.
29. Smith FD, Langeberg LK, Scott JD: The where's and when's of kinase anchoring. Trends Biochem Sci (2006) 31(6):316-323.
30. Vallee RB, DiBartolomeis MJ, Theurkauf WE: A protein kinase bound to the projection portion of MAP 2 (microtubule-associated protein 2). J Cell Biol (1981) 90(3):568-576.
31. Theurkauf WE, Vallee RB: Molecular characterization of the cAMP-dependent protein kinase bound to microtubule-associated protein 2. J Biol Chem (1982) 257(6):3284-3290.
32. Sarkar D, Erlichman J, Rubin CS: Identification of a calmodulin-binding protein that co-purifies with the regulatory subunit of brain protein kinase II. J Biol Chem (1984) 259(15):9840-9846.
33. Carr DW, Stofko-Hahn RE, Fraser ID, Bishop SM, Acott TS, Brennan RG, Scott JD: Interaction of the regulatory subunit (RII) of cAMP-dependent protein kinase with RII-anchoring proteins occurs through an amphipathic helix binding motif. J Biol Chem (1991) 266(22):14188-14192.
34. Carr DW, Hausken ZE, Fraser ID, Stofko-Hahn RE, Scott JD: Association of the type II cAMP-dependent protein kinase with a human thyroid RII-anchoring protein. Cloning and characterization of the RII-binding domain. J Biol Chem (1992) 267(19):13376-13382.
35. Michel JJ, Scott JD: AKAP mediated signal transduction. Annu Rev Pharmacol Toxicol (2002) 42:235-257.
36. Kinderman FS, Kim C, von Daake S, Ma Y, Pham BQ, Spraggon G, Xuong NH, Jennings PA, Taylor SS: A dynamic mechanism for AKAP binding to RII isoforms of cAMP-dependent protein kinase. Mol Cell (2006) 24(3):397-408.
37. Kim C, Vigil D, Anand G, Taylor SS: Structure and dynamics of PKA signaling proteins. Eur J Cell Biol (2006) 85(7):651-654.
38. Wang HY, Tao J, Shumay E, Malbon CC: G protein-coupled receptor-associated A-kinase anchoring proteins: AKAP79 and AKAP250 (gravin). Eur J Cell Biol (2006) 85(7):643-650.
39. Asirvatham AL, Galligan SG, Schillace RV, Davey MP, Vasta V, Beavo JA, Carr DW: A-kinase anchoring proteins interact with phosphodiesterases in T lymphocyte cell lines. J Immunol (2004) 173(8):4806-4814.
40. Schillace RV, Andrews SF, Liberty GA, Davey MP, Carr DW: Identification and characterization of myeloid translocation gene 16b as a novel a kinase anchoring protein in T lymphocytes. J Immunol (2002) 168(4):1590-1599.
41. Dodge-Kafka KL, Soughayer J, Pare GC, Carlisle Michel JJ, Langeberg LK, Kapiloff MS, Scott JD: The protein kinase A anchoring protein mAKAP coordinates two integrated cAMP effector pathways. Nature (2005) 437(7058):574-578.
42. Dodge-Kafka KL, Kapiloff MS: The mAKAP signaling complex: Integration of cAMP, calcium, and MAP kinase signaling pathways. Eur J Cell Biol (2006) 85(7):593-602.
43. Dodge-Kafka KL, Langeberg L, Scott JD: Compartmentation of cyclic nucleotide signaling in the heart: The role of A-kinase anchoring proteins. Circ Res (2006) 98(8):993-1001. •• Provides an exceptional and timely review of the physiological roles of AKAPs with implications for understanding health and disease.
44. McCahill A, McSorley T, Huston E, Hill EV, Lynch MJ, Gall I, Keryer G, Lygren B, Tasken K, van Heeke G, Houslay MD: In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal region. Cell Signal (2005) 17(9):1158-1173.
45. Witczak O, Skålhegg BS, Keryer G, Bornens M, Taskén K, Jahnsen T, Orstavik S: Cloning and characterization of a cDNA encoding an A-kinase anchoring protein located in the centrosome, AKAP450. EMBO J (1999) 18(7):1858-1868.
46. 2-adrenergic receptor. EMBO J (2003) 22(24):6419-6429.
47. 413 domain and provides a mobile scaffold during desensitization. J Biol Chem (2001) 276(26):24005-24014.
48. 2-adrenergic receptor desensitization and resensitization. J Biol Chem (2000) 275(25):19025-19034.
49. Baisamy L, Jurisch N, Diviani D: Leucine zipper-mediated homooligomerization regulates the Rho-GEF activity of AKAP-Lbc. J Biol Chem (2005) 280(15):15405-15412.
50. Diviani D, Abuin L, Cotecchia S, Pansier L: Anchoring of both PKA and 14-3-3 inhibits the Rho-GEF activity of the AKAP-Lbc signaling complex. EMBO J (2004) 23(14):2811-2820.
51. Klauck TM, Faux MC, Labudda K, Langeberg LK, Jaken S, Scott JD: Coordination of three signaling enzymes by AKAP79, a mammalian scaffold protein. Science (1996) 271(5255):1589-1592.
52. Carnegie GK, Scott JD: A-kinase anchoring proteins and neuronal signaling mechanisms. Genes Dev (2003) 17(13):1557-1568.
53. Carnegie GK, Smith FD, McConnachie G, Langeberg LK, Scott JD: AKAP-Lbc nucleates a protein kinase D activation scaffold. Mol Cell (2004) 15(6):889-899.
54. 2-adrenergic receptor resensitization and recycling. J Biol Chem (2007) 282(9):6597-6608. • Provides an excellent example of a detailed analysis of the protein-protein contact site for a tyrosine kinase to an AKAP.
55. 2-adrenergic receptor: Insulin stimulates pp60Src phosphorylation and activation. Mol Biol Cell (2002) 13(11):3943-3954.
56. Shih M, Lin F, Scott JD, Wang HY, Malbon CC: Dynamic complexes of β2-adrenergic receptors with protein kinases and phosphatases and the role of gravin. J Biol Chem (1999) 274(3):1588-1595.
57. Kashishian A, Howard M, Loh C, Gallatin WM, Hoekstra MF, Lai Y: AKAP79 inhibits calcineurin through a site distinct from the immunophilin-binding region. J Biol Chem (1998) 273(42):27412-27419.
58. Dell'Acqua ML, Faux MC, Thorburn J, Thorburn A, Scott JD: Membrane-targeting sequences on AKAP79 bind phosphatidylinositol-4,5- bisphosphate. EMBO J (1998) 17(8):2246-2260.
59. Baillie GS, Scott JD, Houslay MD: Compartmentalisation of phosphodiesterases and protein kinase A: Opposites attract. FEBS Lett (2005) 579(15):3264-3270.
60. Tao J, Shumay E, McLaughlin S, Wang HY, Malbon CC: Regulation of AKAP-membrane interactions by calcium. J Biol Chem (2006) 281(33):23932-23944.
61. Farazi TA, Waksman G, Gordon JI: The biology and enzymology of protein N-myristoylation. J Biol Chem (2001) 276(43):39501-39504.
62. Taniguchi H: Protein myristoylation in protein-lipid and proteinprotein interactions. Biophys Chem (1999) 82(2-3):129- 137.
63. Arbuzova A, Wang L, Wang J, Hangyas-Mihalyne G, Murray D, Honig B, McLaughlin S: Membrane binding of peptides containing both basic and aromatic residues. Experimental studies with peptides corresponding to the scaffolding region of caveolin and the effector region of MARCKS. Biochemistry (2000) 39(33):10330-10339.
64. Murray D, Ben-Tal N, Honig B, McLaughlin S: Electrostatic interaction of myristoylated proteins with membranes: Simple physics, complicated biology. Structure (1997) 5(8):985-989.
65. Dodge K, Scott JD: AKAP79 and the evolution of the AKAP model. FEBS Lett (2000) 476(1-2):58-61.
66. Streb JW, Miano JM: Cross-species sequence analysis reveals multiple charged residue-rich domains that regulate nuclear/cytoplasmic partitioning and membrane localization of A kinase anchoring protein 12 (SSeCKS/gravin). J Biol Chem (2005) 280(30):28007-28014.
67. Gardner LA, Tavalin SJ, Goehring AS, Scott JD, Bahouth SW: AKAP79-mediated targeting of the cyclic AMP-dependent protein kinase to the β1-adrenergic receptor promotes recycling and functional resensitization of the receptor. J Biol Chem (2006) 281(44):33537-33553.
68. Dell'Acqua ML, Smith KE, Gorski JA, Horne EA, Gibson ES, Gomez LL: Regulation of neuronal PKA signaling through AKAP targeting dynamics. Eur J Cell Biol (2006) 85(7):627-633.
69. Smith KE, Gibson ES, Dell'Acqua ML: cAMP-dependent protein kinase postsynaptic localization regulated by NMDA receptor activation through translocation of an A-kinase anchoring protein scaffold protein. J Neurosci (2006) 26(9):2391-2402.
70. Oliveria SF, Gomez LL, Dell'Acqua ML: Imaging kinase-AKAP79- phosphatase scaffold complexes at the plasma membrane in living cells using FRET microscopy. J Cell Biol (2003) 160(1):101-112.
71. Dell'Acqua ML, Dodge KL, Tavalin SJ, Scott JD: Mapping the protein phosphatase-2B anchoring site on AKAP79. Binding and inhibition of phosphatase activity are mediated by residues 315-360. J Biol Chem (2002) 277(50):48796-48802.
72. Gomez LL, Alam S, Smith KE, Horne E, Dell'Acqua ML: Regulation of A-kinase anchoring protein 79/150-cAMP-dependent protein kinase postsynaptic targeting by NMDA receptor activation of calcineurin and remodeling of dendritic actin. J Neurosci (2002) 22(16):7027-7044.
73. Li X, Huston E, Lynch MJ, Houslay MD, Baillie GS: Phosphodiesterase-4 influences the PKA phosphorylation status and membrane translocation of G-protein receptor kinase 2 (GRK2) in HEK-293β2 cells and cardiac myocytes. Biochem J (2006) 394 (Pt 2):427-435.
74. 2- adrenoceptor signalling to activation of ERK. Biochem Soc Trans (2005) 33(Pt 6):1333-1336. •• Provides a critically important paper focusing on how signaling in the fourth dimension can be revealed and understood.
75. Nauert JB, Klauck TM, Langeberg LK, Scott JD: Gravin, an autoantigen recognized by serum from myasthenia gravis patients, is a kinase scaffold protein. Curr Biol (1997) 7(1):52-62.
76. Gelman IH: The role of SSeCKS/gravin/AKAP12 scaffolding proteins in the spaciotemporal control of signaling pathways in oncogenesis and development. Front Biosci (2002) 7:d1782-d1797.
77. Piontek J, Brandt R: Differential and regulated binding of cAMP-dependent protein kinase and protein kinase C isoenzymes to gravin in human model neurons: Evidence that gravin provides a dynamic platform for the localization for kinases during neuronal development. J Biol Chem (2003) 278(40):38970-38979.
78. Malbon CC, Tao J, Shumay E, Wang HY: AKAP (A-kinase anchoring protein) domains: Beads of structure-function on the necklace of G-protein signalling. Biochem Soc Trans (2004) 32(Pt 5):861-864.
79. Malbon CC, Tao J, Wang HY: AKAPs (A-kinase anchoring proteins) and molecules that compose their G-protein-coupled receptor signalling complexes. Biochem J (2004) 379(Pt 1):1-9.
80. Shih M, Lin F, Scott JD, Wang HY, Malbon CC: Dynamic complexes of β2-adrenergic receptors with protein kinases and phosphatases and the role of gravin. J Biol Chem (1999) 274(3):1588-1595.
81. Streb JW, Kitchen CM, Gelman IH, Miano JM: Multiple promoters direct expression of three AKAP12 isoforms with distinct subcellular and tissue distribution profiles. J Biol Chem (2004) 279(53):56014-56023.
82. DeWire SM, Ahn S, Lefkowitz RJ, Shenoy SK: β-Arrestins and cell signaling. Annu Rev Physiol (2007) 69:483-510.
83. Houslay MD, Baillie GS, Maurice DH: cAMP-specific phosphodiesterase-4 enzymes in the cardiovascular system: A molecular toolbox for generating compartmentalized cAMP signaling. Circ Res (2007) 100(7):950-966. •• A classic study on how AKAPs can be considered molecular tool boxes that enable compartmentalization of signaling.
84. Hoshi N, Scott JD: Contextual utilization of enzymes in discrete AKAP79/150 signalling complexes. Eur J Cell Biol (2006) 85(7):621-622.
85. McConnachie G, Langeberg LK, Scott JD: AKAP signaling complexes: Getting to the heart of the matter. Trends Mol Med (2006) 12(7):317-323.
86. Tao J, Shumay E, McLaughlin S, Wang HY, Malbon CC: Regulation of AKAP-membrane interactions by calcium. J Biol Chem (2006) 281(33):23932-23944.
87. Allen JA, Halverson-Tamboli RA, Rasenick MM: Lipid raft microdomains and neurotransmitter signalling. Nat Rev Neurosci (2007) 8(2):128-140.
88. Jacobson K, Mouritsen OG, Anderson RG: Lipid rafts: At a crossroad between cell biology and physics. Nat Cell Biol (2007) 9(1):7-14.
89. Brown DA: Lipid rafts, detergent-resistant membranes, and raft targeting signals. Physiology (2006) 21:430-439.
90. Hill EV, Houslay MD, Baillie GS: Investigation of extracellular signal-regulated kinase 2 mitogen-activated protein kinase phosphorylation and regulation of activity of PDE4 cyclic adenosine monophosphate-specific phosphodiesterases. Methods Mol Biol (2005) 307:225-237.
91. 2-adrenergic receptor to activation of ERK in HEK293B2 cells. J Biol Chem (2005) 280(39):33178-33189.
92. Carlson CR, Lygren B, Berge T, Hoshi N, Wong W, Tasken K, Scott JD: Delineation of type I protein kinase A-selective signaling events using an RI anchoring disruptor. J Biol Chem (2006) 281(30):21535-21545. •• A landmark paper demonstrating the fusion of bioinformatics and peptide arrays to develop new lead compounds in drug discovery that target AKAPs.